Detection of STRP, such as fragile X syndrome
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- BIOCEPT INC
- Publication Date
- 2007-03-07
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1
Abstract
Description
field of invention
[0001] The present invention relates generally to diagnostic tests for hereditary or sporadic genetic defects in adults, fetuses and embryos, and more particularly to the detection of diseases or defects caused by short tandem repeats (STRs), and more particularly to the detection of diseases or defects that cause Fragile X Detection of genetic defects in Fragile X syndrome. These STRP assays use polymerase chain reaction (PCR), which is then hybridized to a microarray and analyzed. Background of the invention
[0002] Eukaryotic DNA has very short tandem repeats of simple sequences called short tandem repeat polymorphisms (STRPs). Repeat polymorphisms include dinucleotide, trinucleotide and tetranucleotide repeats. Trinucleotide and tetranucleotide repeats are repeats of 3 nucleotides and 4 nucleotides. An increasing number of diseases are known to be associated with expansion of trinucleotide STRs (Trottier, Y. et al., Current Biology 3:783-786 (1993)...